Bortezomib Onko (Bortezomib), 3.5 mg, Powder for solution for Injection-Vial

Azacitidine,100 mg, Powder for Injection Suspension- Vial  is used to treat acute myelogenous leukemia, chronic myelogenous leukemia (CML), myelodysplastic syndrome. Contact us for more information.

Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml is used along with cancer chemotherapy to treat bone damage caused by multiple myeloma or by cancer that began in another part of the body but has spread to the bones. Please contact us for more information.
...

Kopaq (Iohexol), Concentrated Solution for Injection - Vial, 300 mgI/ml (50 ml), 300 mgI/ml (100 ml), 350 mgl/ml (50 ml), 350 mgl/ml (100 ml), 350 mgl/ml (200 ml) is a iodinated, nonionic, low osmolar contrast agent.The product is used in arthrography, endoscopic retrograde pancreatography (ERP), endoscopi...

Misintu (Mitomycin), 20 mg, Powder for Solution for Injection/Infusion is used to treat bladder cancer, breast cancer, head and neck cancer, stomach and pancreatic cancer, prostate cancer and cervical cancer. Contact us for more information.

 

Onko Koçsel is proud that Bortezomib Injection 3.5 mg vial DCP application has been successfully accepted by EMA member countries on March, 2021. Onko Koçsel is open for collaboration within and outside EU countries.

Onko Kocsel Factory video